SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hui-Ming Gao, Jau-Shyong Hong, Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease, Progress in Neurobiology, 2011, 94, 1, 1

    CrossRef

  2. 2
    David Crosiers, Jessie Theuns, Patrick Cras, Christine Van Broeckhoven, Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes, Journal of Chemical Neuroanatomy, 2011, 42, 2, 131

    CrossRef

  3. 3
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  4. 4
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  5. 5
    Maria I. Behrens, Norbert Brüggemann, Pedro Chana, Pablo Venegas, Marianne Kägi, Teresa Parrao, Patricia Orellana, Cristian Garrido, Cecilia V. Rojas, Jan Hauke, Eric Hahnen, Rafael González, Nicolas Seleme, Verónica Fernández, Alexander Schmidt, Ferdinand Binkofski, Detlef Kömpf, Christian Kubisch, Johann Hagenah, Christine Klein, Alfredo Ramirez, Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations, Movement Disorders, 2010, 25, 12
  6. 6
    M. Klinkenberg, N. Thurow, S. Gispert, F. Ricciardi, F. Eich, J.H.M. Prehn, G. Auburger, D. Kögel, Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress, Neuroscience, 2010, 166, 2, 422

    CrossRef

  7. 7
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  8. 8
    Christine Klein, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  9. 9
    Enza Maria valente, Alessandro Ferraris, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  10. 10
    Ana Djarmati, Johann Hagenah, Kathrin Reetz, Susen Winkler, Maria Isabel Behrens, Heike Pawlack, Katja Lohmann, Alfredo Ramirez, Vera Tadić, Norbert Brüggemann, Daniela Berg, Hartwig R. Siebner, Anthony E. Lang, Peter P. Pramstaller, Ferdinand Binkofski, Vladimir S. Kostić, Jens Volkmann, Thomas Gasser, Christine Klein, ATP13A2 variants in early-onset Parkinson's disease patients and controls, Movement Disorders, 2009, 24, 14
  11. 11
    Taku Hatano, Shin-ichiro Kubo, Shigeto Sato, Nobutaka Hattori, Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease, Journal of Neurochemistry, 2009, 111, 5
  12. 12
    Enza Maria Valente, Silvia Michiorri, Giuseppe Arena, Vania Gelmetti, PINK1: one protein, multiple neuroprotective functions, Future Neurology, 2009, 4, 5, 575

    CrossRef

  13. 13
    Ryan D. Mills, Chou Hung Sim, Su San Mok, Terrence D. Mulhern, Janetta G. Culvenor, Heung-Chin Cheng, Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1), Journal of Neurochemistry, 2008, 105, 1
  14. 14
    William Lin, Un Jung Kang, Characterization of PINK1 processing, stability, and subcellular localization, Journal of Neurochemistry, 2008, 106, 1
  15. 15
    Sonja Scholz, Andrew Singleton, Susceptibility genes in movement disorders, Movement Disorders, 2008, 23, 7
  16. 16
    Owen A. Ross, Adam T. Braithwaite, Matthew J. Farrer, Parkinson's Disease, 2008,

    CrossRef

  17. 17
    Nathan Pankratz, Tatiana Foroud, Genetics of Parkinson disease, Genetics in Medicine, 2007, 9, 12, 801

    CrossRef

  18. 18
    Christine Klein, Katja Lohmann-Hedrich, Impact of recent genetic findings in Parkinson??s disease, Current Opinion in Neurology, 2007, 20, 4, 453

    CrossRef

  19. 19
    Massimo Zeviani, Valerio Carelli, Mitochondrial disorders, Current Opinion in Neurology, 2007, 20, 5, 564

    CrossRef